Europe Markets for Diabetes Monitoring, Treatment & Drug Delivery Reviewed in New Report Available at MarketPublishers.com

• 

http://marketpublishers.com/

London, UK (PRWEB) February 06, 2013

European diabetes monitoring, treatment and drug delivery market is on the threshold of a new major phase of growth. It is triggered by the rising incidence of diabetes, increasing awareness of healthcare and the blood glucose management. The population suffering from type 2 diabetes grows in number given poor diet, high obesity rates, sedentary life-style and lack of physical exercises; thus driving the growth of demand for products available on the diabetes monitoring, treatment and drug delivery market. Sanofi, Abbott, Terumo, Johnson & Johnson Novo Nordisk, Roche, Medtronic and Becton Dickinson are amid the most prominent participants of the European market for diabetes monitoring, treatment and drug delivery.

By 2019, the European diabetes monitoring, treatment and drug delivery market is set to exhibit a considerable growth in the coming years and to be over EUR 7.6 billion.

New research report “European Markets for Diabetes Monitoring, Treatment and Drug Delivery” worked out by iData Research Inc. has been recently published by Market Publishers Ltd.

Report Details:

Title: European Markets for Diabetes Monitoring, Treatment and Drug Delivery
Published: February, 2013
Pages: 250
Price: US$ 10,995.00
http://marketpublishers.com/report/life_sciences/diagnostics-diseases/european-markets-4-diabetes-monitoring-treatment-n-drug-delivery.html

The report offers an extensive overview of the European diabetes monitoring, treatment and drug delivery markets with a special focus on the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the UK. The research presents comprehensive analyses of the markets on the basis of geography and product segments. The report discloses relevant information on the market size, shape and structure. It traces the prevailing trends and identifies major factors limiting and driving the market growth; evaluates the market concentration, examines the competitive scenario and profiles the top companies. The study also provides data on the recent market activities such as mergers and acquisitions. In addition, future prospects for the European diabetes monitoring, treatment and drug delivery markets up to 2019 are outlined.

Market segments covered in the report: traditional blood glucose monitoring, blood glucose meters, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens, insulin pumps and artificial pancreas.

Reasons to Buy:

•     The report provides an extensive guide to the European diabetes monitoring, treatment and drug delivery markets by providing in-depth analyses of the markets’ segments and information on the market drivers and limiters.
•     The research helps to gain understanding of the market trends by examining market opportunities and barriers as well as describing the market dynamics.
•     Evaluation of the competitive environment and overview of the market activities allow to determine who stands where on the European diabetes monitoring, treatment and drug delivery market and, furthermore, to choose prospective partners.
•     Insightful analysis of the European diabetes monitoring, treatment and drug delivery markets assists in the planning of effective business strategies and in the strengthening of business decisions.
•     Future forecast helps to foresee how the market is set to develop in the upcoming years.

More new research reports by the publisher can be found at iData Research page.

PDF Print